The Complex Landscape of Market Access and Operations in China: How Companies are Rethinking Compliance Amid Intensifying Tariff, Trade and Geopolitical Considerations

Eric Carlson participated in the session "The Complex Landscape of Market Access and Operations in China: How Companies are Rethinking Compliance Amid Intensifying Tariff, Trade and Geopolitical Considerations" at ACI's 21st Annual Anti-Corruption, Fraud & Global Compliance for Life Sciences conference.

Navigating how tariffs and trade policies are reshaping U.S.-China relations with a look at regulatory scrutiny, market access and enforcement risks. Topics included:

• Examining emerging corruption risks with China’s focus on value-based pricing and the compliance challenges stemming from medical education practices
• Creating priorities with the differing regulatory and enforcement approaches of U.S. and China
• Best practices for upholding ethical business practices and adherence to US and Chinese legal frameworks
• Real world perspectives on managing complex issues from the front lines of the life sciences sector
• Lessons learned from the latest cases involving China and what they reveal about future enforcement trends